Bloomios has completed a major expansion of the company’s manufacturing and fulfillment systems at its new 50,000-square-foot manufacturing facility in Daytona Beach, Fla. The expansion increased manufacturing and fulfillment capacity by approximately 300%, as well as lowered operating expenses. It now supports more than 80 turnkey products across seven popular format categories, as well as the company’s plans to enter new market verticals.
Bloomios estimates the new equipment has increased overall capacity by about 300%, while enabling many process improvements. By the third quarter of 2022, the company expects to increase its infused gummy output capacity to exceed more than 1 million gummies per day or a five-times increase in output capacity from current levels.
“Our first quarter was a transitional period where we completed the first phase of our expansion and retooling of our manufacturing facility in preparation for strong growth this year,” stated Bloomios CEO Michael Hill. “While the downtime resulted in lower revenues in the recent period, we anticipate making up for this substantially over the coming quarters as we bring our greater manufacturing capabilities online.”
Bloomios is currently in the process of adding two new stand-alone fully automated filling systems to increase its filling capacity to more than 30,000 containers per day with 10 operators. By the third quarter, it expects to increase its output capacity to more than 45,000 containers daily.
“We do not see these additions requiring any further downtime or affecting our current output,” noted Hill. “In fact, we are already seeing our strengthened production capacity and greater efficiencies positively affecting our revenue and gross margins. These improvements and Bloomios’ one-stop ‘concept-to-creation’ suite of capabilities make us the ideal turnkey solution provider for brands looking to take advantage of today’s booming market in hemp-derived products.”
Near the end of the first quarter, Bloomios announced its entry into the fast-growing sports nutrition and performance market. It has also been actively pursuing potential acquisitions in what it sees as a target-rich M&A environment.
“Given our expanded manufacturing capacity, which extends our ability to rapidly create and launch products into these high growth markets, we continue to see strong growth and market share expansion in 2022,” Hill concluded.
Bloomios manufactures, markets and distributes U.S. hemp-derived supplements and nutraceutical products through wholesale distribution channels and its wholly owned subsidiary, Bloomios Private Label. The company provides custom formulation, brand development, manufacturing and order fulfillment to a wide variety of customers, including small and major brands, chain stores, vape shops and distributors. It offers private- and white-label customers a wide selection of more than 80 customizable hemp products across seven categories. Bloomios is headquartered in Santa Barbara, Calif., with manufacturing and distribution in Daytona Beach.